Daelynn R. Buelow

机构：The Ohio State University · ORCID：0000-0002-4413-5711

发表论文 125 篇 · 总被引 1134 次 · h-index 19

代表论文

• Revumenib in combination with intensive induction and consolidation for newly diagnosed patients with NPM1-mutated or KMT2A-rearranged Acute Myeloid Leukemia: Preliminary results from the Phase 1b etctn 10596 study (2025 · Blood · 被引 2)
• BMX Kinase Modulates Cell-Autonomous and Microenvironmental Niche Interactions to Mediate Gilteritinib Resistance in FLT3-Mutated AML (Abstract ID: 233997) (2026 · Journal of Pharmacology and Experimental Therapeutics)
• OATP1B2 Deficiency Aggravates Docetaxel-Induced Neutropenia in a Translationally Relevant Mouse Model (Abstract ID: 233763) (2026 · Journal of Pharmacology and Experimental Therapeutics)
• Zebrafish as a Model Organism of Decitabine-Induced Myelotoxicity (Abstract ID: 233151) (2026 · Journal of Pharmacology and Experimental Therapeutics)
• Supplementary Figure 5 from Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability (2026)
• Table 1 from Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability (2026)